Flinn Foundation Bioscience Entrepreneurship Program selected six Arizona startups for its 2016 cohort. Each of the companies will receive $30,000 along with mentoring to help them develop into successful and sustainable businesses.
“Following a rigorous and competitive process, we believe these six bioscience startups are excellent representatives of the innovation taking place throughout Arizona,” Jack B. Jewett, President & CEO of the Flinn Foundation, said in a statement. “The services and funding they will receive as participants in the Flinn program will benefit these entrepreneurs as they work to improve the quality of life in Arizona and around the world, while strengthening our state’s economy.”
Of the six startups, the following two are offering digital health-based services:
Breezing
Breezing has created what it says is the world’s first mobile metabolism tracker that measures an individual’s metabolism through breathing. The Tempe-based company tracks one’s metabolism over time and integrates with weight, activity, and dieting goals to provide customized feedback on reaching weight goals.
EpiFinder
EpiFinder’s app enables neurologists to improve the consistency of seizure classification and the accuracy of epilepsy diagnosis. By providing quicker and more accurate diagnoses for a specific epilepsy syndrome, the Scottsdale-based company reduces costs for hospitals, while enabling doctors to provide personalized medicine and helps to improve the quality of life of patients.
Other four companies accepted to the program include Neolight, Omica, Symple Surgical and AniCell Biotech.
In addition to the funding and services, the firms may also participate for one year as members of Arizona’s Bioscience Roadmap Steering Committee, a group of the state’s science, health-care, business, academia and policy leaders responsible for overseeing Arizona’s Bioscience Roadmap.
Over the past three years, the Flinn Foundation has selected 15 bioscience firms to participate in the program.